Private Equity in Healthcare: How Lower Middle-Market Firms Buy, Bid On and Value Healthcare Services Companies

Private equity in healthcare has moved from a niche strategy to one of the most active corners of the lower middle market, and owners of physician practices, dental groups, physical therapy clinics, home health agencies, behavioral health providers and veterinary hospitals are hearing from buyers more often than ever. If you are weighing a sale, it pays to understand how these firms think before the first call, and to work with experienced healthcare business brokers who know how to turn that interest into a competitive process.

This guide explains who the buyers are, how they structure platform and add-on deals, what they examine in diligence, and how they value and bid on healthcare services companies. If you are earlier in your thinking, start with the process for selling a healthcare business, then come back here for a closer look at the private equity side of the table.

Why Private Equity in Healthcare Keeps Growing

Healthcare services remain highly fragmented. Thousands of independent practices and agencies run one to five locations, usually owned by the clinicians who founded them. That fragmentation is the engine of private equity in healthcare, because it lets a buyer assemble a regional group one acquisition at a time.

Demand is durable. Patients need dental cleanings, post-surgical therapy, behavioral health care and home visits in any economy, and an aging population keeps volumes rising. Repeat visits and referral relationships give these businesses a recurring quality investors prize.

Roll-up economics drive much of the activity. A larger group negotiates better payer contracts, centralizes billing and credentialing and spreads overhead across more locations. A practice bought at a smaller-company valuation is worth more inside a larger platform, and the buyer captures that difference.

There is also a succession gap. Many owners are nearing retirement with no associate ready to buy them out, and younger clinicians increasingly prefer employment over ownership. Most private equity in healthcare happens in the lower middle market: privately held companies with a few million dollars of EBITDA, where independent owners still dominate.

Who the Lower Middle-Market Healthcare Buyers Are

Not every buyer that calls is the same, and the differences shape which offers fit your goals.

Traditional Lower Middle-Market Funds

These firms raise committed capital from institutional investors and typically hold companies for four to seven years. Many have dedicated healthcare teams that know reimbursement and compliance well, and they close with reliable financing.

Independent Sponsors

Independent sponsors find a company first, then raise equity for that single deal. They can be flexible on structure and often bring operators with practice management backgrounds, but their financing is less certain until capital partners commit.

Family Offices

Family offices invest the wealth of one or a few families. Many prefer longer holds and less leverage, which appeals to owners who care how their staff will be treated over the next decade. Healthcare expertise varies widely among them.

PE-Backed Portfolio Companies

The most frequent buyer of a smaller practice is a company private equity already owns. A fund-backed dental support organization or multi-state physical therapy group acquires practices to build density in a market, and can pay well because it expects immediate savings from shared services.

Platform vs Bolt-On Acquisitions in Healthcare

What is a platform acquisition?

A platform acquisition is a private equity firm’s first investment in a sector, generally a company with $5 million or more in EBITDA that will serve as the foundation for future growth. The management team usually stays, and the owner often rolls over equity into the new company.

What is a bolt-on or tuck-in acquisition?

A bolt-on or tuck-in acquisition is a smaller company, generally with $1 million or more in EBITDA, that a PE-backed platform buys and integrates into its existing operations. The owner’s role may change, often shifting from running the business to practicing clinically or leading a single location.

How the Difference Affects Price, Structure and Your Role

Platforms usually command a higher multiple because the buyer is paying for a foundation it can build on, including management, systems and brand. Add-ons are priced with the platform’s synergies in mind, so a well-run practice can still attract strong bids when several groups compete for the same market. Structure differs as well. A platform owner should expect a meaningful equity rollover and a continuing leadership role, while an add-on seller may receive more cash at close but give up control of day-to-day decisions. Think carefully about which path matches your plans for the next five years.

What Private Equity Firms Look for in a Healthcare Business

Every healthcare deal turns on a handful of factors, and a strong story on each draws more competition.

Payer Mix and Reimbursement Exposure

Buyers want to know who pays your bills. A balanced mix of commercial insurance, government programs and self-pay patients reduces risk. Heavy reliance on Medicare or Medicaid exposes the business to rate cuts, while heavy out-of-network revenue raises questions about sustainability. Expect buyers to model what happens if your largest payer lowers its rates.

Provider Retention and Employment Agreements

In a clinical business, revenue walks out the door with the providers. Buyers look closely at how long your clinicians have been with you, how they are compensated and whether employment agreements include enforceable non-competes or non-solicitation clauses. Recent changes in state law have made non-competes harder to enforce in some places, which puts more weight on retention incentives.

Regulatory and Compliance History

Clean licensing, accreditation and billing history matter. Buyers will review payer audits, documentation practices, coding accuracy and any past recoupments or investigations. A history of self-audits and a written compliance program signals that the business has been run with care.

Corporate Practice of Medicine and the MSO Structure

Many states prohibit non-physicians from owning medical or dental practices, a doctrine known as the corporate practice of medicine. To invest, private equity firms typically use a management services organization, or MSO. The MSO owns the non-clinical assets and provides administrative services under a long-term agreement, while a licensed clinician continues to own the professional entity. Owners should understand how this structure affects their economics and control.

Same-Location Growth and De Novo Capacity

Buyers want to see that existing locations are growing on their own, not just through acquisitions. Rising visit volume, added chairs or treatment rooms and expanding service lines all help. A proven playbook for opening new locations, known as de novos, adds further value because it gives the buyer another growth lever.

Patient Volume and Referral Sources

Diversified referral sources reduce risk. A physical therapy clinic that depends on one orthopedic group for most of its patients carries more exposure than one with dozens of referring physicians and direct-access patients.

Technology, EHR and Labor Costs

A modern electronic health record and clean practice management data make diligence and integration faster. Buyers also study labor costs closely, because clinical staff wages have risen sharply. Stable staffing, reasonable turnover and limited reliance on agency labor all support value.

Owner Dependence, Concentration, Management and Financials

Beyond the clinical drivers, buyers apply the same tests they use in every industry. A practice that depends on the founder’s personal production or relationships is harder to buy. Concentration among a few payers or referral sources is a risk. A strong practice manager or operations leader adds depth. Clean, accrual-based financials that are ready for a quality of earnings review build credibility and speed up the process.

How Private Equity in Healthcare Values a Practice

Valuation starts with EBITDA, and in healthcare that number almost always needs adjustment. Buyers normalize owner and provider compensation to market rates, because a physician-owner who pays themselves well above or below market distorts earnings. They also remove one-time expenses, personal costs run through the business and non-recurring legal or consulting fees. These add-backs must be documented, since a quality of earnings provider will test each one.

The multiple applied to adjusted EBITDA depends on risk and growth. Diversified payer mix, a deep bench of providers, multiple locations, strong same-location growth and a clean compliance record all push the multiple up. Owner dependence, concentration in one payer or referral source, pending audits and high clinician turnover push it down.

Size matters as well. Companies large enough to serve as a platform typically receive a premium over smaller practices sold as add-ons, because the buyer is paying for scale and infrastructure. Still, an add-on that fills a strategic gap can draw aggressive bids when several groups want the same market.

Lower Middle-Market Private Equity Firms Active in Healthcare

The firms below list healthcare as an investment focus on their own websites and currently own at least one healthcare company. Details come from each firm’s site as of October 2026. Use the list as a starting point for your own research, not a ranking.

Firm details are summarized from each firm’s own website as of October 2026 and can change. Raincatcher is not affiliated with these firms, and inclusion is not an endorsement.

How the Healthcare Auction Process Works

A well-run sale follows a defined sequence that keeps buyers competing and protects confidentiality, and it is how private equity in healthcare typically transacts.

1. Teaser and NDA: An anonymous one-page summary goes to a targeted list of buyers, and interested parties sign a nondisclosure agreement before learning your identity.
2. Confidential information memorandum: Qualified buyers receive a detailed document covering your services, providers, payer mix, locations and financial performance.
3. Indications of interest: Buyers submit non-binding ranges of value and proposed structure, which lets you narrow the field.
4. Management meetings: The strongest buyers meet your leadership team, tour locations and ask detailed questions about operations and growth.
5. Letters of intent: Finalists submit more specific offers covering price, structure, rollover and key terms.
6. Exclusivity: You select one buyer and agree to negotiate only with them for a defined period.
7. Confirmatory due diligence and quality of earnings: The buyer verifies financials, billing practices, compliance, licensing and contracts, usually with an outside accounting firm.
8. Purchase agreement and closing: Lawyers negotiate the definitive agreement, regulatory notices and payer approvals are addressed, and the deal closes.

Most healthcare sales take six to twelve months from preparation to closing, and change-of-ownership filings and payer credentialing can add time.

How PE Firms Submit Competitive Bids for Healthcare Businesses

Headline Price vs Structure

The number at the top of a letter of intent rarely tells the whole story. Cash at close is the most certain component. Rollover equity gives you ownership in the combined company. Earnouts tie part of the price to future performance, which in healthcare can be affected by reimbursement changes you do not control. Seller notes defer payment. The working capital target, especially how accounts receivable are measured, can shift real dollars at closing. Escrows and holdbacks set aside funds for post-closing claims, and representations and warranties insurance may reduce them.

How Competition Improves Price and Terms

When qualified buyers know they are competing, they sharpen price and terms: more cash at close, smaller escrows and better employment terms for your providers. A lone buyer has little reason to improve its first offer.

Comparing Bids Built Differently

Two offers with the same headline value can end very differently. Compare the present value of guaranteed cash, the realistic odds of earning any contingent payments, the strength of the platform you would roll equity into and the buyer’s track record of closing.

What Happens After a Healthcare Practice Sale

If you roll over equity, you share in proceeds when the private equity firm later sells the platform, often called the second bite of the apple. For healthcare groups, that second bite can be meaningful when the group grows through acquisitions.

Most sellers sign employment or transition agreements. Clinicians typically commit to practice for several years, while non-clinical owners may stay through a defined transition. The buyer usually launches a 100-day plan to integrate billing, credentialing, payroll and reporting.

Expect the platform to keep acquiring, and your practice may become a hub for nearby add-ons. Ask how the buyer handles provider autonomy and staff benefits, because those answers shape how your team experiences the change.

How to Prepare a Healthcare Business for a Private Equity Sale

Owners who do well with private equity in healthcare start preparing well before contacting buyers:

• Convert to accrual-based financials and consider a sell-side quality of earnings review.
• Document payer mix, reimbursement rates and collection trends by location.
• Review provider employment agreements, compensation plans and restrictive covenants.
• Commission a coding and billing audit to identify issues before a buyer does.
• Organize licenses, accreditations and credentialing files in one place.
• Build a management layer so the business does not depend on you alone.
• Track same-location growth, visit volume and referral sources monthly.
• Clarify your goals for rollover, your future clinical role and timing.

Once you understand how these buyers think, the next step is putting a realistic number on your own practice, and our guide to valuing a healthcare business walks through the methods and multiples buyers apply.

Frequently Asked Questions

Do private equity firms buy small healthcare practices?

Yes, private equity firms buy small healthcare practices, usually through PE-backed platforms acquiring them as add-ons. A practice with $1 million or more in EBITDA often fits this model, and smaller practices may still attract interest when they fill a geographic or service gap for an existing group.

Can private equity own a medical practice?

Private equity can own a medical practice indirectly in most states through a management services organization. The MSO owns non-clinical assets and provides administrative services, while a licensed clinician owns the professional entity. This structure respects corporate practice of medicine rules while allowing outside investment.

Will I have to keep working after selling to private equity?

You will likely keep working after selling to private equity if you are a producing clinician. Most buyers ask providers to sign employment agreements of several years to protect revenue and patient relationships. Non-clinical owners usually agree to a shorter transition period instead.

Working With Raincatcher

Raincatcher is a sell-side M&A advisor for owners of companies with $2 million to $50 million in revenue. We help healthcare owners prepare their practices, tell their story clearly and run competitive processes that bring multiple lower middle-market buyers to the table, from traditional funds and family offices to PE-backed groups looking for add-ons.

We help you compare offers on more than headline price and reach a closing that fits your financial and personal goals.